Study on the Prevalence of Hyperuricemia and Ethnobotanicals Associated with Gouty Arthritis in Rawalakot, Azad Kashmir

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2022, Vol 6, Issue 1

Abstract

Hyperuricemia prevalence is an exclusive condition in the global populace as it seems to have increased day by day for a long time now. Recent studies recommend that hyperuricemia is an issue and is considered an independent risk. The prevalence of hyperuricemia in the patients of Azad Kashmir and the surveillance of medicinal plants used for this gouty arthritis is relatively low. However, to assess hyperuricemia prevalence in the Rawalakot region of Azad Kashmir, a review study was conducted. The data of the previous three years were retrieved from the Eastern Medicine Teaching Clinic at the University of Poonch, Combined Military Hospital (CMH) Rawalakot, as well as Ali Imran Hospital Rawalakot. Additionally, an ethnobotanical survey was performed to investigate the therapeutic plants utilized to cure gouty arthritis in the Rawalakot region of Azad Kashmir. The study observed a high incidence of hyperuricemia with joint pain in 17.4% of the 189 patients. The percentage of hyperuricemia in males was higher (10.5%) than in females (6.87%). These plants were identified and then evaluated by the local elder people and traditional healers (Hakims). Later on, it was then confirmed by the Botanical Department of University and then preserved. The ethnobotanical study revealed 13 medicinal plants belonging to 11 families used as medicines to treat gouty arthritis. Solanaceae was the most popular family with three species, Datura stramonium, Solanum nigrum, and Withania somnifera. It has been observed that people taking these medicinal plants have significant improvement in gouty arthritis. However, further study needs to be carried out to explore the bioactivity of the plants.

Authors and Affiliations

Aftab A, Akram M, khan FS, Gulzaib U, Hassan S, Hassan MM, Swargiary A, Islam MT, Chishti MA, Bhantana P, Singh A, Amer MM, Aslam MM, Parmar P, Mouna M, Inal B, Ibadi AK, Elkhateeb W* and Daba G

Keywords

Related Articles

Pharmacovigilance - Shaping the Present and Future of Medicines

Pharmacovigilance has an important role in detecting adverse drug reactions. The success of the programme depends on the knowledge and attitude of the involved professionals. Strong Pharmacovigilance programme will help...

Importance of Nanotechnology in Drug Delivery

The branch of technology that deals with dimensions and tolerances of 1-100 nanometres, especially the manipulation of matter on an atomic, molecular and supramolecular scale, is known as ‘Nanotechnology’.

Transdermal Delivery Offer for Low Dose Acetylsalicylic Acid

The use of Acetyl Salicylic Acid (ASA) in the secondary prevention of cardio vascular diseases is well known. Orally administered ASA is rapidly metabolized to its principal metabolite Salicylic Acid (SA) in the gastroin...

IoT and Wearables in Healthcare: Generating Insights from Sensor Data

The convergence of Internet of Things (IoT) devices and wearables within the healthcare sector signifies a paradigm shift, fundamentally altering the dynamics of patient data acquisition and interpretation. This article...

Aegle Marmelos (L.) Correa, A Potential Source for the Treatment of Diabetes Associated Alzheimer’s Disease: A Review

Alzheimer’s disease is a chronic neurodegenerative disorder leading to memory loss, which is caused by progressive wasting away of brain cells. Memory loss leads to changes in a person’s behavior, thinking and social ski...

Download PDF file
  • EP ID EP748604
  • DOI 10.23880/oajpr-16000261
  • Views 55
  • Downloads 0

How To Cite

Aftab A, Akram M, khan FS, Gulzaib U, Hassan S, Hassan MM, Swargiary A, Islam MT, Chishti MA, Bhantana P, Singh A, Amer MM, Aslam MM, Parmar P, Mouna M, Inal B, Ibadi AK, Elkhateeb W* and Daba G (2022). Study on the Prevalence of Hyperuricemia and Ethnobotanicals Associated with Gouty Arthritis in Rawalakot, Azad Kashmir. Open Access Journal of Pharmaceutical Research, 6(1), -. https://europub.co.uk/articles/-A-748604